ADGZX
Price
$25.70
Change
-$3.54 (-12.11%)
Updated
Feb 3 closing price
Net Assets
185.92M
VFIAX
Price
$639.05
Change
+$17.29 (+2.78%)
Updated
Feb 3 closing price
Net Assets
1.47T
Interact to see
Advertisement

ADGZX vs VFIAX

Header iconADGZX vs VFIAX Comparison
Open Charts ADGZX vs VFIAXBanner chart's image
AB Core Opportunities Z
Price$25.70
Change-$3.54 (-12.11%)
VolumeN/A
Net Assets185.92M
Vanguard 500 Index Admiral
Price$639.05
Change+$17.29 (+2.78%)
VolumeN/A
Net Assets1.47T
ADGZX vs VFIAX Comparison Chart in %
View a ticker or compare two or three
VS
ADGZX vs. VFIAX commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADGZX is a Buy and VFIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VFIAX has more cash in the bank: 1.48T vs. ADGZX (186M). VFIAX pays higher dividends than ADGZX: VFIAX (1.10) vs ADGZX (0.00). ADGZX was incepted earlier than VFIAX: ADGZX (12 years) vs VFIAX (25 years). ADGZX (0.85) is less costly to investors than VFIAX (0.04). ADGZX is a more actively managed with annual turnover of: 46.00 vs. VFIAX (2.00). VFIAX has a lower initial minimum investment than ADGZX: VFIAX (3000) vs ADGZX (2000000). VFIAX annual gain was more profitable for investors over the last year : 15.49 vs. ADGZX (-1.12). VFIAX return over 5 years is better than : 78.94 vs. ADGZX (8.94).
ADGZXVFIAXADGZX / VFIAX
Total Expense Ratio0.840.042,100%
Annual Report Gross Expense Ratio0.850.042,125%
Fund Existence12 years25 years-
Gain YTD-0.8101.141-71%
Front LoadN/AN/A-
Min. Initial Investment2000000300066,667%
Min. Initial Investment IRAN/AN/A-
Net Assets186M1.48T0%
Annual Yield % from dividends0.001.10-
Returns for 1 year-1.1215.49-7%
Returns for 3 years26.0267.5639%
Returns for 5 years8.9478.9411%
Returns for 10 years54.40268.6120%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DALVX22.630.08
+0.35%
Dunham Large Cap Value A
TGIWX15.22-0.07
-0.46%
Nuveen Core Equity W
RYHCX94.41-0.91
-0.95%
Rydex Health Care C
LMNOX55.40-0.56
-1.00%
Patient Opportunity I
MRIGX30.05-0.68
-2.21%
Meridian Growth Investor